Market Place
Sourcing Support
Alkeus Pharmaceuticals Appoints David Arkowitz as CFO
31 Oct 2024 //
GLOBENEWSWIRE
Alkeus Study Shows Gildeuretinol Slows GA Progression
23 Oct 2024 //
GLOBENEWSWIRE
Alkeus Pharmaceuticals Presents Data At AAO 2024 Meeting
17 Oct 2024 //
GLOBENEWSWIRE
Alkeus` Eye Disease Drug Fails To Reduce Lesion Growth In Phase 3
18 Sep 2024 //
FIERCE BIOTECH
Alkeus Announces SAGA Study Results for Gildeuretinol
17 Sep 2024 //
GLOBENEWSWIRE
Alkeus Presents TEASE-3 Update On Gildeuretinol For Stargardt Disease
18 Jul 2024 //
GLOBENEWSWIRE
Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer
16 Jul 2024 //
GLOBENEWSWIRE
Accomplished Biotech Leader Michel Dahan Joins Alkeus as President and CEO
02 Jul 2024 //
GLOBENEWSWIRE
Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer
29 May 2024 //
GLOBENEWSWIRE
Alkeus Positive Interim Results In Stargardt Disease
08 May 2024 //
GLOBENEWSWIRE
Alkeus: Positive Gildeuretinol Data In Stargardt At ARVO 2024
01 May 2024 //
GLOBENEWSWIRE
Alkeus Pharmaceuticals Appoints Seemi Khan, M.D., Chief Medical Officer
23 Jan 2024 //
GLOBENEWSWIRE
Alkeus says its eye therapy halts progression of genetic disease
11 Jan 2024 //
HEALTH ET
Alkeus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
21 Dec 2023 //
GLOBENEWSWIRE
Alkeus Pharmaceuticals Presents Positive Gildeuretinol Trial Results
03 Nov 2023 //
GLOBENEWSWIRE
Alkeus Announces $150 Million Series B Financing
05 Jun 2023 //
GLOBENEWSWIRE
FDA Grants Alkeus Breakthrough Therapy Designation for ALK-001
14 Jul 2021 //
GLOBENEWSWIRE
FDA awards $18 million to fund trials of medical products for rare diseases
01 Oct 2018 //
HEALIO
FDA awards 12 grants to fund new clinical trials for rare diseases
24 Sep 2018 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.